March 24, 2021 Warsaw, Poland

Dear Colleagues,

After careful consideration of the COVID-19 pandemic, the recent notifications issued by the WHO, the Polish Ministry of Health and the evolving travel restrictions worldwide, the Organizing Committee of the Brain Tumors made a decision to host the meeting to June 22-24, 2022 to ensure safety for our delegates, speakers and sponsors. The safety, health and well-being of all our attendees will always be of extreme importance to us.

Most of the speakers have already confirmed their participation, so the program is not significantly changed

We are looking forward to welcoming you to Warsaw in June 2022! We will prepare and disseminate the new program in the next few days. The administrative details, registration fee, and venue remain the same. 

The online services will remain in place for the new meeting date and the registration for new attendees will be still open.


See You in Warsaw

Prof. Bozena Kaminska


Chair of the Organizing Committee

Confirmed plenary speakers:
John de Groot, MD Anderson Cancer Center, USA

Confirmed speakers:
Kenneth Aldape, National Cancer Institute, USA
Oren Becher, Mount Sinai, USA
Martin van den Bent, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Etty (Tika) Benveniste, University of Alabama at Birmingham, USA
Agnieszka Bronisz, Harvard Medical School/Mossakowski Medical Institute, Poland
Maria G. Castro, University of Michigan Medical School, USA
Waldemar Debinski, Wake Forest Baptist Health, Comprehensive Cancer Center, USA
Neta Erez, Tel Aviv University, Israel
Dinorah Friedmann-Morvinski, Tel Aviv University, Israel
Constantinos G. Hadjipanayis, Icahn School of Medicine, Mount Sinai, USA
Dolores Hambardzumyan, Icahn School of Medicine, Mount Sinai, USA
Petra Hamerlik, Danish Cancer Society Research Center, Denmark
Dieter Henrik Heiland, University of Freiburg Medical Center, Germany 
Christel Herold-Mende, University of Heidelberg, Germany
Katrin Lamszus, University Medical Center Hamburg-Eppendorf, Germany
Bozena Kaminska, Nencki Institute of Experimental Biology, Poland
Anna Kenney, Winship Cancer Institute, Emory University, USA
Jacek Majewski, McGill University, Canada
Alessandro Michelucci, Luxemburg Institute of Health, Luxemburg
Houtan Noushmehr, Henry Ford Health System, USA
Waldemar Priebe, MD Anderson Cancer Center, USA
Guido Reifenberger, University of Dusseldorf, Germany
Itay Tirosh, Weizmann Institute of Science, Isreal
Maciej Wiznerowicz, International Institute for Molecular Oncology, Poland